80

Kristine E Ensrud1,2,3, John T Schousboe4,5, Carolyn J Crandall6

  • 1Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis.

JAMA network open
|June 28, 2024
PubMed
概括

像FRAX和Garvan这样的骨折风险评估工具没有改善80岁以上成年人的部骨折预测. 仅仅是股骨部骨矿物质密度 (FNBMD) 是一个更好的预测指标,尽管临床医生应该考虑骨质密度,预期寿命和患者的偏好.